JCB logo
Accuri Cytometers
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 12780K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kok, J. W.
Right arrow Articles by Hoekstra, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kok, J. W.
Right arrow Articles by Hoekstra, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

© The Rockefeller University Press, 0021-9525/1998//25 $5.00
The Journal of Cell Biology, Volume 142, Number 1, , 1998 25-38


Articles

PDMP Blocks Brefeldin A–induced Retrograde Membrane Transport from Golgi to ER: Evidence for Involvement of Calcium Homeostasis and Dissociation from Sphingolipid Metabolism



Jan Willem Kok*, Teresa Babia§, Catalin M. Filipeanu{ddagger}, Adriaan Nelemans{ddagger}, Gustavo Egea§, and Dick Hoekstra*

* Department of Physiological Chemistry, {ddagger} Department of Clinical Pharmacology, University of Groningen, Groningen Institute for Drug Studies (GIDS), 9713 AV Groningen, The Netherlands; and § Universitat de Barcelona, Facultat de Medicina, Departament de Biologia Cellular, Institut d'Investigacions Biomediques August Pi I Sunyer, 08036 Barcelona, Spain

In this study, we show that an inhibitor of sphingolipid biosynthesis, D,L-threo-1-phenyl-2- decanoylamino-3-morpholino-1-propanol (PDMP), inhibits brefeldin A (BFA)-induced retrograde membrane transport from Golgi to endoplasmic reticulum (ER). If BFA treatment was combined with or preceded by PDMP administration to cells, disappearance of discrete Golgi structures did not occur. However, when BFA was allowed to exert its effect before PDMP addition, PDMP could not "rescue" the Golgi compartment.

Evidence is presented showing that this action of PDMP is indirect, which means that the direct target is not sphingolipid metabolism at the Golgi apparatus. A fluorescent analogue of PDMP, 6-(N-[7-nitro-2,1,3-benzoxadiazol-4-yl]amino)hexanoyl-PDMP (C6-NBD-PDMP), did not localize in the Golgi apparatus. Moreover, the effect of PDMP on membrane flow did not correlate with impaired C6-NBD-sphingomyelin biosynthesis and was not mimicked by exogenous C6-ceramide addition or counteracted by exogenous C6-glucosylceramide addition. On the other hand, the PDMP effect was mimicked by the multidrug resistance protein inhibitor MK571.

The effect of PDMP on membrane transport correlated with modulation of calcium homeostasis, which occurred in a similar concentration range. PDMP released calcium from at least two independent calcium stores and blocked calcium influx induced by either extracellular ATP or thapsigargin. Thus, the biological effects of PDMP revealed a relation between three important physiological processes of multidrug resistance, calcium homeostasis, and membrane flow in the ER/ Golgi system.

Key Words: ceramide • retrograde membrane flow • β-COP • multidrug resistance • intracellular calcium



Abbreviations used in this paper: BFA, brefeldin A; Cer, ceramide; C6-NBD, 6-(N-[7-nitro-2,1,3-benzoxadiazol-4-yl]amino)hexanoyl or hexanoic acid; GlcCer, glucosylceramide; ManII, mannosidase II; MDR, multidrug resistance; MRP, multidrug resistance protein; NRK, normal rat kidney; PDMP, D,L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol; P-gp, P-glycoprotein; SM, sphingomyelin.

The research of Jan Willem Kok has been made possible by a fellowship of the Royal Netherlands Academy of Arts and Sciences (KNAW). Teresa Babia was supported by a grant from the Comissio Interdepartamental de Recerca i Innovacio Tecnologia. Gustavo Egea was supported by a grant from the Comissio Interdepartamental de Ciencia y Tecnologia (SAF 97/0016). Catalin M. Filipeanu is a recipient of an Ubbo Emmius fellowship from the Groningen Utrecht Institute for Drug Exploration.

Address all correspondence to J.W. Kok, Department of Physiological Chemistry, University of Groningen, Groningen Institute for Drug Studies (GIDS), A. Deusinglaan 1, 9713 AV Groningen, The Netherlands. Tel.: 31-(0)50-3632725. Fax: 31-(0)50-3632728. E- mail: j.w.kok{at}med.rug.nl



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents